Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 43% —
Register , to see more distinctive signs of diseases and studies — 88%
body odor
41%
—
glycogenoses —
82%
yellow fever
41%
—
empty —
72%
fever abdominal pain
37%
—
amyloidosis —
65%
bad breath unpleasant
37%
—
liver dystrophy
41%
95%
periodic fainting
36%
—
mushroom poisoning —
44%
acute hepatitis
86%
49%
chronic liver failure —
43%
acute viral hepatitis
82%
46%
hepatosis fatty
57%
100%
sudden onset
34%
—
diffuse liver changes —
43%
pain in the mouth
34%
—
hepatoses
56%
98%
confusion of thoughts
32%
—
nitrate poisoning —
42%
loses thought
32%
—
worse from mushrooms —
41%
hallucinations
32%
—
cholestatic hepatitis —
40%
sudden pain
32%
—
deep coma —
39%
liver necrosis
65%
33%
fermentopathy —
39%
fainting
30%
—
metabolic alkalosis —
38%
disorders of consciousness
29%
—
cirrhosis of the liver
50%
88%
psychosis
29%
—
feeling of isolation —
37%
abdominal pain
28%
—
viral hepatitis d —
37%
confusion
28%
—
biliary cirrhosis of the liver —
36%
unspecified mental disorders
28%
—
alkalosis —
36%
madness
28%
—
obesity
46%
81%
general intoxication syndrome
28%
—
hepatic coma
44%
78%
abdominal swelling
59%
30%
emphysema —
33%
ascites
63%
34%
dystrophy
45%
78%
pain throughout the body
27%
—
heaviness in the liver —
33%
jaundice
55%
28%
coma
33%
64%
high temperature
25%
—
obesity 2 st
40%
71%
there are no complaints
60%
35%
pancreatopathy —
30%
bleeding
41%
18%
liver failure
31%
61%
swelling
43%
22%
metabolic acidosis —
30%
patient's condition
61%
50%
chronic respiratory failure —
29%
reduction of LDL
68%
60%
pain in the veins —
29%
hepatitis
75%
67%
motor anxiety —
29%
necrosis
68%
60%
sadness —
29%
reduction of HDL
65%
58%
effects of poisoning —
27%
reduction of ggtp
63%
56%
moderate condition —
27%
violation of fat metabolism
56%
49%
sharp belly —
27%
cytolysis syndrome
61%
54%
respiratory insufficiency —
26%
hepatic encephalopathy
61%
54%
drug poisoning —
26%
reduction of tg
58%
51%
blood loss —
26%
portal hypertension
58%
51%
bacteremia —
26%
hepatic cell carcinoma
57%
50%
worse food —
26%
type 2 diabetes mellitus
57%
50%
kidney failure —
25%
insulin deficiency
57%
50%
sepsis —
25%
excess insulin
57%
50%
overweight
44%
68%
increase ggtp
62%
55%
control issues —
24%
increased cholesterol levels in the blood
54%
47%
chronic kidney disease —
24%
dyslipidemia
57%
50%
thrombosis —
24%
alt reduction
55%
48%
treatment with antibiotics —
23%
polymorbidity
53%
46%
toxic hepatitis
31%
54%
grandmother diabetes
55%
48%
chronic viral hepatitis
38%
58%
liver is indurated
52%
46%
cholestasis
52%
72%
bacterial overgrowth syndrome
54%
48%
abdominal obesity
39%
59%
medicinal hepatotoxicity
52%
46%
hepatitis chronic
38%
58%
metabolic syndrome
52%
46%
violation of carbohydrate metabolism
51%
70%
increased cholesterol
52%
46%
toxic liver
51%
70%
intoxication
51%
45%
liver pain
24%
43%
hepatitis c
51%
45%
dysfunction of the gallbladder
46%
64%
total blood protein
48%
42%
hypertrophy biliary tract
49%
67%
antinuclear factor
50%
44%
liver dysfunction
50%
68%
encephalopathy
50%
44%
hepatitis b
51%
69%
reduction of ast
54%
48%
food poisoning
34%
51%
intrahepatic cholestasis
57%
51%
protein reduced
22%
39%
medicinal hepatitis
46%
40%
protein with increased
30%
45%
hyperammonemia
55%
49%
blood diseases
38%
52%
varicose veins of the esophagus
47%
41%
sensitivity to medications
27%
41%
consumes alcohol
48%
42%
bleeding
18%
32%
increased HDL
56%
50%
consequences of taking medications
37%
50%
gallbladder stones
50%
44%
consequences of infection
35%
48%
increased fatigue
48%
42%
liver diseases
70%
74%
cardiac cirrhosis of the liver
48%
42%
lipid metabolism
53%
47%
lower cholesterol
56%
50%
increased adiponectin
56%
50%
dull complexion
35%
30%
antibodies to smooth muscle
38%
33%
diseases of the gastrointestinal tract
40%
35%
inflammation of the stomach
38%
33%
de nol
39%
34%
onset of illness
39%
34%
impaired glucose tolerance
39%
34%
abdominal distension a
40%
35%
dysbacteriosis
37%
32%
impaired function of the large intestine
39%
34%
reduction of ldh
40%
35%
diabetes mellitus
43%
38%
heart dysfunction
44%
39%
decrease in atherogenicity
43%
38%
metabolic disorder
43%
38%
alcohol is abusing
41%
36%
heaviness in the right hypochondrium
43%
38%
atherosclerosis of blood vessels
43%
38%
expansion of the esophagus
42%
37%
blindness
44%
39%
increased alt
42%
37%
hypertension
42%
37%
decreased lipase
42%
37%
insulin resistance index decreased
41%
36%
hormonal disorders
42%
37%
cardiac disorder
40%
35%
anomalies of esophageal development
42%
37%
IBS
44%
39%
red palms
42%
37%
benign neoplasms
44%
39%
fear of water
45%
40%
increased ferritin
48%
43%
enlarged liver
47%
42%
alcoholic liver disease
48%
43%
vascular tumor
40%
35%
damage to the nervous system
40%
35%
hypertension
46%
41%
bursting pain in the right hypochondrium
46%
41%
adiponectin reduced
41%
36%
inflammatory bowel diseases
46%
41%
omega vaccinations
45%
40%
congenital liver fibrosis
41%
36%
fibromyalgia
45%
40%
cancer
41%
36%
up circulatory disorders
41%
36%
thickness of posterior wall of left ventricle is increased
41%
36%
prostate enlargement
30%
26%
skin problems
30%
26%
polypragmasy
30%
26%
weight change
31%
27%
choleretic
30%
26%
circadian rhythm disorders
30%
26%
swelling of the legs
31%
27%
sebaceous gland adenoma
31%
27%
constant weakness
30%
26%
cardiomegaly
31%
27%